Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Lyra Therapeutics, Inc. - Common Stock (NQ:LYRA)

11.85 -1.65 (-12.22%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 12, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Lyra Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 Next >
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Let's have a look at the top gainers and losers in the middle of the day of today's session.
Curious about what's happening in today's session? Check out the latest stock movements and price changes. 
Via Chartmill
Is the Market Bullish or Bearish on Lyra Therapeutics?
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Lyra Therapeutics Stock: A Deep Dive Into Analyst Perspectives (4 Ratings)
Via Benzinga
Where Lyra Therapeutics Stands With Analysts
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
What's going on in today's session
Curious to know what's happening on the US markets one hour before the close of the markets on Tuesday? Join us as we explore the top gainers and losers in today's session. 
Via Chartmill
Which stocks are moving on Tuesday?
Here are the top movers in Tuesday's session, showcasing the stocks with significant price changes. 
Via Chartmill
US Stocks Likely To Open Lower: Expert Highlights Technical Analysis Showing S&P 500's 'Recovery Is Real' And Not A 'Bull Trap' Or 'Bear Market Rally'
U.S. stock futures fell on Tuesday after a higher close on Monday. Futures of major benchmark indices declined in premarket. 
Via Benzinga
Topics Stocks
Exposures US Equities
Nasdaq Surges Over 100 Points Despite Renewed Trade Concerns: Investor Sentiment Improves, Fear Index Remains In 'Greed' Zone
Via Benzinga
Applied Digital Corp, Meta Platforms, Alphabet, Lyra Therapeutics, Tesla: Why These 5 Stocks Are On Investors' Radars Today
U.S. stocks closed higher on Monday, with the Dow Jones Industrial Average inching up 0.08% to 42,305.48, the S&P 500 advancing 0.4% to 5,935.94. 
Via Benzinga
Topics Stocks
Exposures US Equities
Lyra Therapeutics Stock Skyrockets On Positive Trial Data For Its Nasal Implant: Retail’s Thrilled
LYR-210 demonstrated statistically significant improvement compared to sham control in key symptoms of chronic rhinosinusitis, such as nasal obstruction, nasal discharge, and facial pain/pressure at... 
Via Stocktwits
Exposures COVID-19 Product Safety
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Nasdaq Edges Higher; ISM Manufacturing PMI Falls In May
Via Benzinga
Dow Dips Over 300 Points; Campbell's Posts Upbeat Earnings
Via Benzinga
Topics Stocks
Exposures US Equities
Why Is Lyra Therapeutics Stock Surging Over 400% On Monday?
Lyra's LYR-210 met key goals in a Phase 3 trial for chronic rhinosinusitis, showing early and sustained symptom relief with a favorable safety profile. 
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Why Blueprint Medicines Shares Are Trading Higher By 27%; Here Are 20 Stocks Moving Premarket
Via Benzinga
What's going on in today's pre-market session
Wondering what's happening in Tuesday's pre-market session? Find an overview in this article. 
Via Chartmill
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
US Stocks Likely To Open Lower After S&P 500's Six-Day Streak: 'Quick Recoveries Tend To See Stocks Rally More Over The Next 3-12 Months,' Says Expert
U.S. stock futures were slightly lower on Tuesday after ending largely flat on Monday. Futures of major benchmark indices were trading lower in premarket. 
Via Benzinga
Topics Stocks
Exposures US Equities
Why Pegasystems Shares Are Trading Higher By Over 6%; Here Are 20 Stocks Moving Premarket
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
LYRA Stock Earnings: Lyra Therapeutics Beats EPS, Beats Revenue for Q2 2024
LYRA stock results show that Lyra Therapeutics beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. 
Via InvestorPlace
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
It's time to start the day with a breakdown of the biggest pre-market stock movers traders need to keep an eye on for Tuesday! 
Via InvestorPlace
Dow Surges Over 100 Points; EyePoint Pharmaceuticals Shares Plunge
Via Benzinga
Topics Stocks
Exposures US Equities
Crude Oil Gains 1%; TreeHouse Foods Shares Fall After Q1 Results
Via Benzinga
Exposures Fossil Fuels
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.